Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + amoxicillin vs esomeprazole + amoxicillin for first-line Helicobacter pylori eradication
ChiCTR2300069762Phase 4Recruiting
- Sponsor
- No. 945 Hospital of the Chinese People's Liberation Army Joint Logistics Support Force
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Helicobacter pylori infection, chronic gastritis and Peptic ulcer disease (PUD) comparing vonoprazan + amoxicillin with Control: esomeprazole + amoxicillin (2 arms). Primary endpoint: Helicobacter pylori eradication rate. Started Jun 2022; status: recruiting.
02
Drugs
vonoprazanesomeprazoleamoxicillin
03
Conditions
Helicobacter pylori infectionchronic gastritisPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on ChiCTR2300069762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069762.